Login / Signup

A rationale for blocking thromboinflammation in COVID-19 with Btk inhibitors.

Phillip Lindsay Ross NicolsonJohn D WelshAbhishek ChauhanMark R ThomasMark L KahnSteve P Watson
Published in: Platelets (2020)
Keyphrases
  • coronavirus disease
  • sars cov
  • tyrosine kinase
  • clinical trial
  • respiratory syndrome coronavirus